Press Room http://www.news.sanofi.us/ MediaRoom Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process http://www.news.sanofi.us/Appeals-Court-Grants-Stay-of-Permanent-Injunction-for-Praluent-R-alirocumab-During-Appeals-Process - Praluent continues to be available to patients in the U.S. - Wed, 08 Feb 2017 18:44:00 -0500 http://www.news.sanofi.us/Appeals-Court-Grants-Stay-of-Permanent-Injunction-for-Praluent-R-alirocumab-During-Appeals-Process Sanofi Delivers 2016 Sales and Business EPS Growth at CER http://www.news.sanofi.us/2017-02-08-Sanofi-Delivers-2016-Sales-and-Business-EPS-Growth-at-CER Wed, 08 Feb 2017 07:30:00 -0500 http://www.news.sanofi.us/2017-02-08-Sanofi-Delivers-2016-Sales-and-Business-EPS-Growth-at-CER Sanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States http://www.news.sanofi.us/2017-02-01-Sanofis-Xyzal-R-Allergy-24HR-Approved-for-Over-the-Counter-Use-in-the-United-States - Antihistamine Offers 24-Hour Relief to Adults and Children with Seasonal and Year-Round Allergies - Wed, 01 Feb 2017 08:00:00 -0500 http://www.news.sanofi.us/2017-02-01-Sanofis-Xyzal-R-Allergy-24HR-Approved-for-Over-the-Counter-Use-in-the-United-States Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases http://www.news.sanofi.us/2017-01-09-Sanofi-and-ImmuNext-Enter-into-Agreement-to-Develop-Treatments-for-Autoimmune-Diseases Mon, 09 Jan 2017 08:00:00 -0500 http://www.news.sanofi.us/2017-01-09-Sanofi-and-ImmuNext-Enter-into-Agreement-to-Develop-Treatments-for-Autoimmune-Diseases Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection http://www.news.sanofi.us/Sanofi-and-Regeneron-to-Appeal-U-S-District-Court-Rulings-in-Ongoing-Patent-Litigation-Regarding-Praluent-alirocumab-Injection Thu, 05 Jan 2017 22:27:00 -0500 http://www.news.sanofi.us/Sanofi-and-Regeneron-to-Appeal-U-S-District-Court-Rulings-in-Ongoing-Patent-Litigation-Regarding-Praluent-alirocumab-Injection